(Reuters) - Five big U.S. retailers filed an antitrust lawsuit against Pfizer Inc and India's Ranbaxy Laboratories Ltd on Thursday, accusing them of conspiring to delay sales of generic versions of ...

NEW YORK -- Pfizer Inc. and India's Ranbaxy Laboratories Ltd. said today they have settled their patent dispute over the blockbuster cholesterol drug Lipitor, delaying the release of generic versions ...

Ranbaxy Laboratories Limited, announced today that it has made an agreement with Pfizer Inc. to settle most of the patent litigation worldwide involving the cholesterol-lowering medicine ...

(Reuters) - Pharmaceutical giant Pfizer is facing a mounting wave of lawsuits by women who allege that the company knew about possible serious side effects of its blockbuster anti-cholesterol drug ...

New York, NY - Pfizer has announced that it is ending its US promotional activities for its branded statin, Lipitor (atorvastatin). The product lost its patent protection in the US last November, but ...

BOMBAY, Oct. 12 -- A London court upheld a patent on Pfizer Inc.'s blockbuster anti-cholesterol drug Lipitor on Wednesday, handing Pfizer a key victory by blocking Ranbaxy Laboratories Ltd. of India ...

US pharmaceutical company Pfizer last week triumphed in a long-awaited court decision that, if upheld, will stop generics companies from copying its blockbuster cholesterol-lowering drug Lipitor until ...

December 9, 2011 (Pomona, California) — Pfizer's tactics to try to retain Lipitor (atorvastatin) sales in the face of generic competition is again the subject of concern, this time in a Perspective ...

WASHINGTON — When "diet and exercise isn't enough," Pfizer still wants consumers to ask their doctor about Lipitor — just not Dr. Robert Jarvik. On Monday, Pfizer took the doctor and inventor of the ...